Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
C2.1.D |
By Age: <15 |
2015 |
4,691 |
C2.1.D |
By Age: 15+ |
2015 |
65,610 |
C2.1.D |
By Age/Sex: <15 Female |
2015 |
2,017 |
C2.1.D |
By Age/Sex: <15 Male |
2015 |
2,675 |
C2.1.D |
By Age/Sex: 15+ Female |
2015 |
35,734 |
C2.1.D |
By Age/Sex: 15+ Male |
2015 |
29,874 |
C2.1.D |
By Sex: Female |
2015 |
37,988 |
C2.1.D |
By Sex: Male |
2015 |
32,313 |
C2.1.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
70,301 |
C2.1.D |
Sum of Age disaggregates |
2015 |
70,301 |
C2.1.D |
Sum of Age/Sex disaggregates |
2015 |
70,300 |
C2.1.D |
Sum of Sex disaggregates |
2015 |
70,301 |
C2.1.D_NA |
By Age: <15 |
2015 |
418 |
C2.1.D_NA |
By Age: 15+ |
2015 |
5,973 |
C2.1.D_NA |
By Age/Sex: <15 Female |
2015 |
174 |
C2.1.D_NA |
By Age/Sex: <15 Male |
2015 |
242 |
C2.1.D_NA |
By Age/Sex: 15+ Female |
2015 |
3,255 |
C2.1.D_NA |
By Age/Sex: 15+ Male |
2015 |
2,720 |
C2.1.D_NA |
By Sex: Female |
2015 |
2,894 |
C2.1.D_NA |
By Sex: Male |
2015 |
3,497 |
C2.1.D_NA |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
6,391 |
C2.1.D_NA |
Sum of Age disaggregates |
2015 |
6,391 |
C2.1.D_NA |
Sum of Age/Sex disaggregates |
2015 |
6,391 |
C2.1.D_NA |
Sum of Sex disaggregates |
2015 |
6,391 |
C2.1.D_NGI |
By Age: <15 |
2015 |
6,060 |
C2.1.D_NGI |
By Age: 15+ |
2015 |
85,240 |
C2.1.D_NGI |
By Age/Sex: <15 Female |
2015 |
2,590 |
C2.1.D_NGI |
By Age/Sex: <15 Male |
2015 |
3,470 |
C2.1.D_NGI |
By Age/Sex: 15+ Female |
2015 |
46,430 |
C2.1.D_NGI |
By Age/Sex: 15+ Male |
2015 |
38,810 |
C2.1.D_NGI |
By Sex: Female |
2015 |
49,020 |
C2.1.D_NGI |
By Sex: Male |
2015 |
42,280 |
C2.1.D_NGI |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
91,300 |
C2.1.D_NGI |
Sum of Age disaggregates |
2015 |
91,300 |
C2.1.D_NGI |
Sum of Age/Sex disaggregates |
2015 |
91,300 |
C2.1.D_NGI |
Sum of Sex disaggregates |
2015 |
91,300 |
C2.4.D |
Number of HIV-positive patients who were screened for TB in HIV care or treatment setting |
2015 |
91,300 |
CARE_NEW |
Age/sex: <1 Female |
2015 |
20 |
CARE_NEW |
Age/sex: <1 Male |
2015 |
20 |
CARE_NEW |
Age/sex: 1-4 Female |
2015 |
137 |
CARE_NEW |
Age/sex: 1-4 Male |
2015 |
101 |
CARE_NEW |
Age/sex: 10-14 Female |
2015 |
61 |
CARE_NEW |
Age/sex: 10-14 Male |
2015 |
60 |
CARE_NEW |
Age/sex: 15-19 Female |
2015 |
141 |
CARE_NEW |
Age/sex: 15-19 Male |
2015 |
121 |
CARE_NEW |
Age/sex: 20-24 Female |
2015 |
282 |
CARE_NEW |
Age/sex: 20-24 Male |
2015 |
171 |
CARE_NEW |
Age/sex: 25-49 Female |
2015 |
1,815 |
CARE_NEW |
Age/sex: 25-49 Male |
2015 |
2,128 |
CARE_NEW |
Age/sex: 5-9 Female |
2015 |
61 |
CARE_NEW |
Age/sex: 5-9 Male |
2015 |
61 |
CARE_NEW |
Age/sex: 50+ Female |
2015 |
333 |
CARE_NEW |
Age/sex: 50+ Male |
2015 |
539 |
CARE_NEW |
Aggregated Age/sex: <15 Female |
2015 |
278 |
CARE_NEW |
Aggregated Age/sex: <15 Male |
2015 |
242 |
CARE_NEW |
Aggregated Age/sex: 15+ Female |
2015 |
2,571 |
CARE_NEW |
Aggregated Age/sex: 15+ Male |
2015 |
2,959 |
CARE_NEW |
Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
6,050 |
CARE_NEW |
Sum of Age/sex disaggregates |
2015 |
6,051 |
CARE_NEW |
Sum of Aggregated Age/sex disaggregates |
2015 |
6,050 |
CARE_SITE |
By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole |
2015 |
2 |
CARE_SITE |
By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing clinical care services |
2015 |
2 |
CARE_SITE |
By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole |
2015 |
23 |
CARE_SITE |
By site support type: Technical Assistance-only (TA): Total number of PEPFAR supported sites providing clinical care services |
2015 |
25 |
CARE_SITE |
Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole |
2015 |
25 |
CARE_SITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
25 |
CARE_SITE |
Total number of PEPFAR supported sites providing clinical care services |
2015 |
27 |
CARE_SITE_den |
Sum of Denominator Site Support Type disaggregates |
2015 |
27 |
QI_SITE |
By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months |
2015 |
8 |
QI_SITE |
By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, HTC |
2015 |
8 |
QI_SITE |
By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months |
2015 |
52 |
QI_SITE |
By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
52 |
QI_SITE |
Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months |
2015 |
60 |
QI_SITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
60 |
QI_SITE |
Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
60 |
QI_SITE_den |
Sum of Denominator Site Support Type disaggregates |
2015 |
60 |
SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
10 |
SITE_SUPP |
By program area/support type: Care and Support Technical Assistance-only (TA) |
2015 |
76 |
SITE_SUPP |
By program area/support type: TB/HIV Direct Service Delivery (DSD) |
2015 |
8 |
SITE_SUPP |
By program area/support type: TB/HIV Technical Assistance-only (TA) |
2015 |
53 |
SITE_SUPP |
By program area/support type: Treatment Direct Service Delivery (DSD) |
2015 |
10 |
SITE_SUPP |
By program area/support type: Treatment Technical Assistance-only (TA) |
2015 |
53 |
TB_ART |
Age: 0-4 |
2015 |
135 |
TB_ART |
Age: 15+ |
2015 |
2,457 |
TB_ART |
Age: 5-14 |
2015 |
108 |
TB_ART |
Aggregated Age: <15 |
2015 |
243 |
TB_ART |
Aggregated Age: 15+ |
2015 |
2,457 |
TB_ART |
Female |
2015 |
1,269 |
TB_ART |
Known HIV-positive |
2015 |
2,100 |
TB_ART |
Male |
2015 |
1,431 |
TB_ART |
Newly tested |
2015 |
900 |
TB_ART |
Sum of Aggregated Age disaggregates |
2015 |
2,700 |
TB_ART |
Sum of Sex disaggregates |
2015 |
2,700 |
TB_ART |
Sum of Test Status disaggregates |
2015 |
3,000 |
TB_ART |
The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period |
2015 |
3,000 |
TB_ART |
The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period |
2015 |
2,700 |
TB_ARTSITE |
By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units |
2015 |
8 |
TB_ARTSITE |
By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period |
2015 |
6 |
TB_ARTSITE |
By site support type: Technical Assistance-only (TA): The number of PEPFAR-supported TB basic management units |
2015 |
48 |
TB_ARTSITE |
By site support type: Technical Assistance-only (TA): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period |
2015 |
40 |
TB_ARTSITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
46 |
TB_ARTSITE |
The number of PEPFAR-supported TB basic management units |
2015 |
86 |
TB_ARTSITE |
The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period |
2015 |
86 |
TB_ARTSITE_den |
Sum of Denominator Site Support Type disaggregates |
2015 |
56 |
TB_SCREEN |
The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period |
2015 |
91,300 |
TX_CURR |
Age/Sex: <1 Female |
2015 |
3 |
TX_CURR |
Age/Sex: <1 Female |
2015 |
3 |
TX_CURR |
Age/Sex: <1 Male |
2015 |
3 |
TX_CURR |
Age/Sex: <1 Male |
2015 |
3 |
TX_CURR |
Age/Sex: 1-4 Female |
2015 |
29 |
TX_CURR |
Age/Sex: 1-4 Female |
2015 |
13 |
TX_CURR |
Age/Sex: 1-4 Male |
2015 |
21 |
TX_CURR |
Age/Sex: 1-4 Male |
2015 |
11 |
TX_CURR |
Age/Sex: 15+ Female |
2015 |
997 |
TX_CURR |
Age/Sex: 15+ Female |
2015 |
268 |
TX_CURR |
Age/Sex: 15+ Male |
2015 |
991 |
TX_CURR |
Age/Sex: 15+ Male |
2015 |
278 |
TX_CURR |
Age/Sex: 5-14 Female |
2015 |
44 |
TX_CURR |
Age/Sex: 5-14 Female |
2015 |
12 |
TX_CURR |
Age/Sex: 5-14 Male |
2015 |
37 |
TX_CURR |
Age/Sex: 5-14 Male |
2015 |
12 |
TX_CURR |
Aggregated Age/Sex: <1 Female |
2015 |
3 |
TX_CURR |
Aggregated Age/Sex: <1 Female |
2015 |
3 |
TX_CURR |
Aggregated Age/Sex: <1 Male |
2015 |
3 |
TX_CURR |
Aggregated Age/Sex: <1 Male |
2015 |
3 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
76 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
28 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
61 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
26 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
997 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
268 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
991 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
278 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
2,125 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
600 |
TX_CURR |
Percent children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] |
2015 |
5 |
TX_CURR |
Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] |
2015 |
49 |
TX_CURR |
Sum of age/sex disaggregates |
2015 |
54 |
TX_CURR |
Sum of Age/Sex disaggregations |
2015 |
137 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
137 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
54 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
1,988 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
546 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
2,125 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
600 |
TX_CURR_NGI |
Age/Sex: <1 Female |
2015 |
5 |
TX_CURR_NGI |
Age/Sex: <1 Male |
2015 |
4 |
TX_CURR_NGI |
Age/Sex: 1-4 Female |
2015 |
34 |
TX_CURR_NGI |
Age/Sex: 1-4 Male |
2015 |
25 |
TX_CURR_NGI |
Age/Sex: 15+ Female |
2015 |
1,387 |
TX_CURR_NGI |
Age/Sex: 15+ Male |
2015 |
1,416 |
TX_CURR_NGI |
Age/Sex: 5-14 Female |
2015 |
54 |
TX_CURR_NGI |
Age/Sex: 5-14 Male |
2015 |
49 |
TX_CURR_NGI |
Aggregated Age/Sex: <1 Female |
2015 |
5 |
TX_CURR_NGI |
Aggregated Age/Sex: <1 Male |
2015 |
4 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Female |
2015 |
93 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Male |
2015 |
78 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Female |
2015 |
1,387 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Male |
2015 |
1,416 |
TX_CURR_NGI |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
2,974 |
TX_CURR_NGI |
Sum of Age/Sex disaggregates |
2015 |
2,974 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex <15 |
2015 |
171 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex 15+ |
2015 |
2,803 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex disaggregates |
2015 |
2,974 |
TX_DIST |
Number of Districts with documented routine supportive supervision visits to 75% of HIV care and treatment sites supported by the District |
2015 |
4 |
TX_DIST |
Total number of PEPFAR supported District Health Offices |
2015 |
4 |
TX_NEW |
Aggregated Grouping by Age: <1 Male |
2015 |
2 |
TX_NEW |
Aggregated Grouping by Age/Sex: <1 Female |
2015 |
3 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Female |
2015 |
46 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Male |
2015 |
43 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2015 |
400 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2015 |
450 |
TX_NEW |
By Age/Sex: <1 Female |
2015 |
3 |
TX_NEW |
By Age/Sex: <1 Male |
2015 |
2 |
TX_NEW |
By Age/Sex: 1-4 Female |
2015 |
22 |
TX_NEW |
By Age/Sex: 1-4 Male |
2015 |
20 |
TX_NEW |
By Age/Sex: 10-14 Female |
2015 |
9 |
TX_NEW |
By Age/Sex: 10-14 Male |
2015 |
9 |
TX_NEW |
By Age/Sex: 15-19 Female |
2015 |
26 |
TX_NEW |
By Age/Sex: 15-19 Male |
2015 |
17 |
TX_NEW |
By Age/Sex: 20-24 Female |
2015 |
40 |
TX_NEW |
By Age/Sex: 20-24 Male |
2015 |
30 |
TX_NEW |
By Age/Sex: 25-49 Female |
2015 |
337 |
TX_NEW |
By Age/Sex: 25-49 Male |
2015 |
272 |
TX_NEW |
By Age/Sex: 5-9 Female |
2015 |
10 |
TX_NEW |
By Age/Sex: 5-9 Male |
2015 |
10 |
TX_NEW |
By Age/Sex: 50+ Female |
2015 |
49 |
TX_NEW |
By Age/Sex: 50+ Male |
2015 |
83 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
939 |
TX_NEW |
Sum of Age/Sex disaggregates |
2015 |
939 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2015 |
939 |